Target Innovation & Novel Screening Technologies - ELRIG's German Forum

18 Feb 2025

VKU, Berlin

Event overview

In the rapidly evolving landscape of drug discovery, the identification and validation of novel therapeutic targets are pivotal to expanding the druggable genome and tackling unmet medical needs. This forum focuses on novel targets and the cutting-edge methodologies and technological innovations that are greatly advancing the tractable target space. The forum will bring together leading academic and industry experts to reflect on the latest approaches, opportunities and challenges to exploit historically challenging and novel target classes using state-of-the-art methodologies.

 

Forum Directors 

Susanne Mueller-Knapp

Saman Honarnejad

Confirmed speakers –

Martin Schroeder – Novartis

Katharina Duerr – Omass

Marc Nazare – FMP

Hauke Cornils – Evotec

Lukas Friedrich – Merck Healthcare Kgaa

Kamyar Hadian – Helmholtz Munich

Interested in becoming an

Exhibitor or Sponsor?

Although all ELRIG events are free of charge, we rely on our
valued exhibitors and sponsors to help fund our future events.

Menu